From: Meeting program
Treatment | n(%) |
---|---|
Total patients treated w/epinephrine | 102 (79.1) |
EpiPen (self-administered) | 24 (18.6) |
Epinephrine via ED personnel | 86 (66.7) |
IV access secured | 76 (58.9) |
IV fluid bolus | 35 (27.1) |
H1 antagonists | 122 (94.6) |
H2 antagonists | 32 (24.8) |
Corticosteroids | 64 (49.6) |
β2-Agonists | 38 (29.5) |
Admitted to hospital after initial mgt | 8 (6.2) |
Discharge Dx = anaphylaxis | 53 (41.1) |
EpiPen prescribed on discharge | 76 (58.9) |
Discharge therapy/adviceDischarge prescription including corticosteroids | 37 (28.7)8 (6.2) |